
Analysts Viewpoint
A company insider recently sold 1,480 shares of KalVista Pharmaceuticals Inc [KALV]. Should You Sale?
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. KalVista Pharmaceuticals